Recordati

About Recordati

Recordati is a global pharmaceutical company headquartered in the UK, dedicated to the research, development, manufacturing, and marketing of innovative medicines. Established in 1926, the company has a rich history of providing high-quality healthcare solutions that address unmet medical needs.

With a strong focus on rare diseases and specialty pharmaceuticals, Recordati aims to improve the quality of life for patients around the world. The company’s extensive portfolio includes treatments for various therapeutic areas, including cardiovascular, urology, and central nervous system disorders.

Recordati is committed to advancing medical science through rigorous research and development efforts. The company invests significantly in clinical trials and collaborations with leading research institutions to bring new therapies to market.

In addition to its dedication to innovation, Recordati places a strong emphasis on sustainability and corporate social responsibility. The company actively engages in initiatives that promote environmental stewardship and community well-being.

Recordati operates in over 30 countries, with a diverse workforce that reflects its commitment to inclusivity and diversity. The company fosters a culture of collaboration and continuous improvement, empowering employees to contribute to its mission of enhancing patient care.

As a trusted partner in the healthcare industry, Recordati collaborates with healthcare professionals, patients, and stakeholders to ensure access to essential medications. The company’s vision is to be a leader in the pharmaceutical sector, recognized for its innovative solutions and dedication to patient health.

Through its ongoing efforts, Recordati strives to make a meaningful impact on global health, ensuring that patients receive the best possible care and treatment options.